Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
Authors:
- Hakki CetinkayaHCHakki Cetinkaya
- Meltem GursuMGMeltem Gursu
- Halil YaziciHYHalil Yazici
- Egemen CebeciECEgemen Cebeci
- Necmi ErenNENecmi Eren
- Mehmet Riza AltiparmakMAMehmet Riza Altiparmak
- Omer Faruk AkcayOAOmer Faruk Akcay
- Gulizar SahinGSGulizar Sahin
- Hamad DheirHDHamad Dheir
- Taner BasturkTBTaner Basturk
- Kadir Gokhan AtilganKAKadir Gokhan Atilgan
- Nihal AydemirNANihal Aydemir
- 10 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 37 (4) , 923-932
Abstract
Background Immunoglobulin A nephropathy (IgAN) is a common primary glomerulonephropathy. There is evidence that mesangial C3 deposition plays a role in the development of the disease. The aim of this study was to examine the effect of C3 deposition on the prognosis of IgAN patients. Method The study included 1135 patients with biopsy-confirmed IgAN from the database of the Turkish Nephrology Association Glomerular Diseases Working Group (TSN-GOLD). Patients were excluded from the study if they were aged < 18 or > 75 years or if C3 staining had not been performed in the immunofluorescent analysis. C3 deposition was defined as an immunofluorescence intensity of C3 ≥ 2 + within the mesangium. The primary endpoints were the development of end-stage renal disease, a 30% decrease in glomerular filtration rate compared to the basal value or an elevation in proteinuria to a nephrotic level (3.5 gr/day). Results Mesangial C3 deposition was observed in 603 (53.1%) patients. No statistically significant difference was found at baseline between the groups with and without mesangial C3 deposition, as for age, sex, BMI, proteinuria level, or the presence of hypertension. In the follow-up period with a mean duration of 78 months, no significant difference was found between the two groups regarding the primary endpoints (p = 0.43). A significant correlation between C3 deposition and segmental glomerulosclerosis (S1) according to the Oxford MEST-C classification was found (p = 0.001). Conclusion Although a correlation was observed between mesangial C3 deposition and the S1 MEST-C classification, mesangial C3 deposition was not a prognostic factor in IgAN. Graphical abstractKeywords
This publication has 26 references indexed in Scilit:
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsKidney International, 2014
- Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No ProteinuriaJournal of the American Society of Nephrology, 2012
- Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA NephropathyPLOS ONE, 2012
- The Use of the Oxford Classification of IgA Nephropathy to Predict Renal SurvivalClinical Journal of the American Society of Nephrology, 2011
- Validation of the Oxford classification of IgA nephropathyKidney International, 2011
- The incidence of primary glomerulonephritis worldwide: a systematic review of the literatureNephrology Dialysis Transplantation, 2010
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classificationKidney International, 2009
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLOS Medicine, 2007
- IgACEJournal of the American Society of Nephrology, 2007
- Regression of IgA nephropathy: A repeat biopsy studyAmerican Journal of Kidney Diseases, 2002